• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Introduction to 4-(Hydrazinylmethyl)pyridine trihydrochloride (CAS No. 1349717-75-4)

4-(Hydrazinylmethyl)pyridine trihydrochloride, with the chemical formula C?H??Cl?N?, is a significant compound in the field of pharmaceutical chemistry and drug discovery. This trihydrochloride salt of 4-(hydrazinylmethyl)pyridine has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The compound’s molecular structure, featuring a pyridine core substituted with a hydrazinylmethyl group, makes it a versatile intermediate for synthesizing various pharmacologically active molecules.

The compound’s significance is further underscored by its role in the development of novel therapeutic agents. In recent years, there has been growing interest in exploring the pharmacological properties of hydrazine derivatives, particularly those incorporating nitrogen-containing heterocycles like pyridine. The presence of the hydrazinylmethyl moiety suggests potential interactions with biological targets, making it a valuable scaffold for drug design.

4-(Hydrazinylmethyl)pyridine trihydrochloride has been studied in the context of its reactivity and ability to form coordination complexes with metal ions. This property is particularly relevant in the development of metal-based therapeutics, where such compounds can act as chelating agents or catalysts in biochemical processes. The trihydrochloride form enhances the compound’s solubility and stability, making it more suitable for various chemical and biological assays.

Recent research has highlighted the compound’s potential in addressing neurological disorders. The pyridine ring is a common structural motif in many central nervous system (CNS) drugs due to its ability to cross the blood-brain barrier and interact with neuronal receptors. The hydrazinylmethyl group may contribute to modulating neurotransmitter activity, offering a promising avenue for developing treatments for conditions such as epilepsy, depression, and neurodegenerative diseases.

The synthesis of 4-(Hydrazinylmethyl)pyridine trihydrochloride involves multi-step organic reactions, typically starting from commercially available pyridine derivatives. The introduction of the hydrazinylmethyl group requires careful control of reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research and development purposes.

In addition to its pharmaceutical applications, 4-(Hydrazinylmethyl)pyridine trihydrochloride has shown promise in material science. Its ability to form stable complexes with metal ions makes it useful in catalysis and as a ligand for industrial processes. The compound’s unique electronic properties also make it a candidate for developing novel materials with applications in electronics and sensors.

The safety profile of 4-(Hydrazinylmethyl)pyridine trihydrochloride is an important consideration in its handling and application. While preliminary studies suggest that the compound is generally well-tolerated, further research is needed to fully understand its toxicological properties. Standard laboratory practices should be followed when working with this compound, including proper ventilation, personal protective equipment (PPE), and waste disposal protocols.

The future directions of research on 4-(Hydrazinylmethyl)pyridine trihydrochloride are promising. Ongoing studies aim to explore its mechanism of action in greater detail and identify new therapeutic applications. Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate the development of novel drugs based on this compound’s structural framework.

In conclusion, 4-(Hydrazinylmethyl)pyridine trihydrochloride (CAS No. 1349717-75-4) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and potential applications make it a valuable asset in drug discovery and material science. As research continues to uncover new possibilities for this compound, its role in developing innovative therapies and materials is expected to grow.

• 3731-53-1(4-(Aminomethyl)pyridine)
• 57037-80-6(4-(1-Hydrazinylethyl)pyridine)
• 7112-39-2(4-pyridylmethylhydrazine)
• 57616-01-0(2-((pyridin-3-yl)methyl)hydrazine hydrochloride)
• 7112-38-1(3-(Hydrazinylmethyl)pyridine)
• 1149588-41-9(2-((pyridin-4-yl)methyl)hydrazine hydrochloride)
• 64460-41-9(Pyridin-4-ylmethanamine hydrochloride)
• 18205-56-6(Pyridin-4-ylmethanamine dihydrochloride)
• 6978-97-8(3-pyridylmethylhydrazine;dihydrochloride)
• 89598-56-1(4-(Hydrazinylmethyl)pyridine dihydrochloride)